In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR
A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a com...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-06-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2019.00561/full |
id |
doaj-d84dba8a105c4caa88387877f25b7d8e |
---|---|
record_format |
Article |
spelling |
doaj-d84dba8a105c4caa88387877f25b7d8e2020-11-24T20:43:06ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122019-06-011010.3389/fphar.2019.00561449547In Silico Toxicology Data Resources to Support Read-Across and (Q)SARGopal PawarJudith C. MaddenDavid EbbrellJames W. FirmanMark T. D. CroninA plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data.https://www.frontiersin.org/article/10.3389/fphar.2019.00561/fulldatabasesin silicochemicalsdrugssafety assessment |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Gopal Pawar Judith C. Madden David Ebbrell James W. Firman Mark T. D. Cronin |
spellingShingle |
Gopal Pawar Judith C. Madden David Ebbrell James W. Firman Mark T. D. Cronin In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR Frontiers in Pharmacology databases in silico chemicals drugs safety assessment |
author_facet |
Gopal Pawar Judith C. Madden David Ebbrell James W. Firman Mark T. D. Cronin |
author_sort |
Gopal Pawar |
title |
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
title_short |
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
title_full |
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
title_fullStr |
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
title_full_unstemmed |
In Silico Toxicology Data Resources to Support Read-Across and (Q)SAR |
title_sort |
in silico toxicology data resources to support read-across and (q)sar |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2019-06-01 |
description |
A plethora of databases exist online that can assist in in silico chemical or drug safety assessment. However, a systematic review and grouping of databases, based on purpose and information content, consolidated in a single source, has been lacking. To resolve this issue, this review provides a comprehensive listing of the key in silico data resources relevant to: chemical identity and properties, drug action, toxicology (including nano-material toxicity), exposure, omics, pathways, Absorption, Distribution, Metabolism and Elimination (ADME) properties, clinical trials, pharmacovigilance, patents-related databases, biological (genes, enzymes, proteins, other macromolecules etc.) databases, protein-protein interactions (PPIs), environmental exposure related, and finally databases relating to animal alternatives in support of 3Rs policies. More than nine hundred databases were identified and reviewed against criteria relating to accessibility, data coverage, interoperability or application programming interface (API), appropriate identifiers, types of in vitro, in vivo,-clinical or other data recorded and suitability for modelling, read-across, or similarity searching. This review also specifically addresses the need for solutions for mapping and integration of databases into a common platform for better translatability of preclinical data to clinical data. |
topic |
databases in silico chemicals drugs safety assessment |
url |
https://www.frontiersin.org/article/10.3389/fphar.2019.00561/full |
work_keys_str_mv |
AT gopalpawar insilicotoxicologydataresourcestosupportreadacrossandqsar AT judithcmadden insilicotoxicologydataresourcestosupportreadacrossandqsar AT davidebbrell insilicotoxicologydataresourcestosupportreadacrossandqsar AT jameswfirman insilicotoxicologydataresourcestosupportreadacrossandqsar AT marktdcronin insilicotoxicologydataresourcestosupportreadacrossandqsar |
_version_ |
1716820635388215296 |